Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that
Karachi: A notice regarding the loss of share certificates has been issued by CCHST Pakistan Limited, detailing the loss of several certificates belonging to Mr. Zahid Hussain. Dated July 29, 2025, the announcement emphasizes the need for members of t…
Karachi: A notice regarding the loss of share certificates has been issued by CCHST Pakistan Limited, detailing the loss of several certificates belonging to Mr. Zahid Hussain. Dated July 29, 2025, the announcement emphasizes the need for members of t…
Karachi: The Board of Directors for Mari Energies Limited met recently, and according to the company’s communication dated July 21, 2025, the meeting concluded without any announcement concerning the release of price-sensitive information. Market part…
Karachi: The Board of Directors for Mari Energies Limited met recently, and according to the company’s communication dated July 21, 2025, the meeting concluded without any announcement concerning the release of price-sensitive information. Market part…
Karachi: Sanghar Sugar Mills Limited has announced its financial results for the nine-month period ending June 30, 2025. The announcement was made following a Board of Directors meeting held on July 29, 2025, in Karachi. The board approved the release…
Karachi: Thal Limited has released details concerning its upcoming Extraordinary General Meeting, set to take place on August 06, 2025. The company has published the ballot paper for voting in the meeting in leading newspapers, Business Recorder and D…
